T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Canadian Natural Resources
CNQ
|
+$759M |
| 3 |
Becton Dickinson
BDX
|
+$735M |
| 4 |
Ashland
ASH
|
+$669M |
| 5 |
Keysight
KEYS
|
+$573M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTX Corp
RTX
|
+$1.73B |
| 2 |
Ecolab
ECL
|
+$1.17B |
| 3 |
Crown Castle
CCI
|
+$906M |
| 4 |
Phillips 66
PSX
|
+$775M |
| 5 |
Gilead Sciences
GILD
|
+$756M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.4% |
| 5 | Technology | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
UGI
UGI
$7.53B
| $2.17M | ﹤0.01% |
57,240
-7,500
| -12% | -$277K |
|
|
INXN
1552
DELISTED
Interxion Holding N.V.
INXN
| $2.17M | ﹤0.01% |
+79,206
| New | +$2.15M |
|
1553
Alliant Energy
LNT
$18.2B
| $2.16M | ﹤0.01% |
65,096
| – | – |
|
|
SCTY
1554
DELISTED
SolarCity Corporation
SCTY
| $2.15M | ﹤0.01% |
40,194
-2,834
| -7% | -$152K |
|
|
HCAP
1555
DELISTED
Harvest Capital Credit Corporation
HCAP
| $2.14M | ﹤0.01% |
185,400
| – | – |
|
|
ASPX
1556
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $2.12M | ﹤0.01% |
+40,359
| New | +$1.19M |
|
1557
W.P. Carey
WPC
$16.1B
| $2.08M | ﹤0.01% |
30,375
+7,811
| +35% | +$516K |
|
1558
Casey's General Stores
CASY
$31B
| $2.08M | ﹤0.01% |
23,000
| – | – |
|
1559
AXIS Capital
AXS
$7.26B
| $2.07M | ﹤0.01% |
40,574
+1,674
| +4% | +$81.9K |
|
|
CYN
1560
DELISTED
CITY NATIONAL CORPORATION
CYN
| $2.06M | ﹤0.01% |
25,450
-2,800
| -10% | -$216K |
|
|
Y
1561
DELISTED
Alleghany Corp
Y
| $2.05M | ﹤0.01% |
4,426
-10
| -0.2% | -$4.45K |
|
1562
Synopsys
SNPS
$79B
| $2.05M | ﹤0.01% |
47,067
+843
| +2% | +$35K |
|
|
TAST
1563
DELISTED
Carrols Restaurant Group, Inc.
TAST
| $2.04M | ﹤0.01% |
267,236
-1,071,042
| -80% | -$7.99M |
|
|
ASNA
1564
DELISTED
Ascena Retail Group, Inc.
ASNA
| $2.03M | ﹤0.01% |
8,087
-1,450
| -15% | -$360K |
|
1565
Lear
LEA
$8.16B
| $2.03M | ﹤0.01% |
20,700
-3,000
| -13% | -$276K |
|
1566
Avnet
AVT
$7.98B
| $2.01M | ﹤0.01% |
46,798
-300
| -0.6% | -$12.7K |
|
|
FUEL
1567
DELISTED
Rocket Fuel Inc.
FUEL
| $2.01M | ﹤0.01% |
124,841
+29,770
| +31% | +$493K |
|
1568
NVR
NVR
$16.8B
| $1.99M | ﹤0.01% |
1,563
| – | – |
|
|
BRCD
1569
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $1.95M | ﹤0.01% |
164,925
-18,786
| -10% | -$204K |
|
1570
Wolfspeed
WOLF
$1.64B
| $1.95M | ﹤0.01% |
60,415
+1,537
| +3% | +$50.5K |
|
|
BEAV
1571
DELISTED
B/E Aerospace Inc
BEAV
| $1.93M | ﹤0.01% |
33,258
-12,671
| -28% | -$706K |
|
|
PRE
1572
DELISTED
PARTNERRE LTD
PRE
| $1.9M | ﹤0.01% |
16,600
+500
| +3% | +$57K |
|
1573
Carlisle Companies
CSL
$15.2B
| $1.89M | ﹤0.01% |
20,944
| – | – |
|
|
SPLK
1574
DELISTED
Splunk Inc
SPLK
| $1.86M | ﹤0.01% |
31,500
+5,200
| +20% | +$319K |
|
|
WR
1575
DELISTED
Westar Energy Inc
WR
| $1.85M | ﹤0.01% |
44,950
| – | – |
|
Similar funds
T. Rowe Price Associates's Q4 2014 Portfolio in Review
As of Q4 2014, T. Rowe Price Associates held 2,627 positions worth $471B, up 2.8% from $458B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q4 2014 filing shows 87 new, 929 increased, 999 reduced and 89 closed positions. Its largest new stake was Keysight: 17,553,953 shares worth $593M. The largest sale was RTX Corp, an estimated $1.73B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q4 2014 buy was Keysight: 17,553,953 shares worth $593M.
- T. Rowe Price Associates added most to Allergan plc in Q4 2014, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2014 reduction was RTX Corp, cutting an estimated $1.73B.
- T. Rowe Price Associates fully exited ATHLON ENERGY INC COM in Q4 2014, selling an estimated $499M.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $471B portfolio in Q4 2014.
- T. Rowe Price Associates opened 87 new positions and closed 89 in Q4 2014.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $471B.
Based on T. Rowe Price Associates's 13F filing for Q4 2014, filed 13 Feb 2015.